Peregrine Capital Management LLC Purchases 80,369 Shares of Ardent Health Partners, LLC (NYSE:ARDT)

Peregrine Capital Management LLC lifted its position in Ardent Health Partners, LLC (NYSE:ARDT) by 30.8% during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 341,235 shares of the company’s stock after buying an additional 80,369 shares during the period. Peregrine Capital Management LLC’s holdings in Ardent Health Partners were worth $5,828,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other large investors also recently modified their holdings of the company. Rhumbline Advisers increased its position in shares of Ardent Health Partners by 23.9% during the 4th quarter. Rhumbline Advisers now owns 16,913 shares of the company’s stock valued at $289,000 after purchasing an additional 3,266 shares during the last quarter. Allspring Global Investments Holdings LLC grew its stake in shares of Ardent Health Partners by 9.2% during the 4th quarter. Allspring Global Investments Holdings LLC now owns 779,601 shares of the company’s stock valued at $13,136,000 after acquiring an additional 65,833 shares during the period. R Squared Ltd purchased a new stake in Ardent Health Partners in the 4th quarter worth approximately $37,000. Oliver Luxxe Assets LLC bought a new stake in Ardent Health Partners during the 4th quarter worth approximately $1,465,000. Finally, JPMorgan Chase & Co. purchased a new position in Ardent Health Partners during the third quarter valued at approximately $154,000.

Ardent Health Partners Stock Up 1.0 %

Shares of ARDT opened at $14.92 on Wednesday. The company has a quick ratio of 1.78, a current ratio of 1.91 and a debt-to-equity ratio of 0.78. Ardent Health Partners, LLC has a 1 year low of $13.63 and a 1 year high of $20.72. The business’s 50 day simple moving average is $15.56 and its 200-day simple moving average is $16.95.

Analyst Ratings Changes

A number of analysts have recently issued reports on ARDT shares. Truist Financial reduced their price objective on shares of Ardent Health Partners from $22.00 to $21.00 and set a “buy” rating for the company in a research note on Monday, January 6th. JPMorgan Chase & Co. reissued a “neutral” rating and set a $20.00 price target on shares of Ardent Health Partners in a report on Tuesday, December 17th. Bank of America lowered Ardent Health Partners from a “buy” rating to a “neutral” rating and dropped their price objective for the stock from $22.00 to $19.00 in a research note on Wednesday, November 6th. Royal Bank of Canada reiterated an “outperform” rating and set a $23.00 target price on shares of Ardent Health Partners in a research report on Thursday, November 14th. Finally, Leerink Partners boosted their price target on Ardent Health Partners from $23.00 to $25.00 and gave the stock an “outperform” rating in a report on Tuesday, November 12th. Two investment analysts have rated the stock with a hold rating, eight have issued a buy rating and two have given a strong buy rating to the company’s stock. According to MarketBeat, the company presently has a consensus rating of “Buy” and an average target price of $21.55.

Ardent Health Partners Company Profile

Ardent Health Partners, Inc owns and operates a network of hospitals and clinics that provides a range of healthcare services in the United States. It operates acute care hospitals, including rehabilitation hospitals and surgical hospitals. The company was founded in 2001 and is based in Brentwood, Tennessee.